Lupin jumps as arm receives USFDA approval for Generic Lexapro Tablets

14 Sep 2012 Evaluate

Lupin is currently trading at Rs. 605.55, up by 6.35 points or 1.06% from its previous closing of Rs. 599.20 on the BSE.

The scrip opened at Rs. 620.00 and has touched a high and low of Rs. 620.00 and Rs. 604.10 respectively. So far 7,147 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 631.90 on 10-Sep-2012 and a 52 week low of Rs. 409.50 on 14-Dec-2011.

Last one week high and low of the scrip stood at Rs. 631.90 and Rs. 596.85 respectively. The current market cap of the company is Rs. 27,058.00 crore.

The promoters holding in the company stood at 46.91% while Institutions and Non-Institutions held 43.97% and 9.12% respectively.

Lupin’s subsidiary - Lupin Pharmaceuticals Inc. has received final approval for its Escitalopram Tablets (Escitalopram oxalate) 5 mg, 10 mg, and 20 mg strengths from the United States Food and Drugs Administration (FDA) to market a generic version of Forest Laboratories, Inc.’s (Forest) Lexapro Tablets, 5 mg, 10 mg, and 20 mg.

Lupin’s Escitalopram Tablets 5 mg, 10 mg, and 20 mg is the AB-rated generic equivalent of Forest's Lexapro Tablets and is indicated for acute and maintenance treatment of major depressive disorder in adults and adolescents aged 12-17 years. It is also indicated for the acute treatment of general anxiety disorder in adults.

Lexapro Tablets had annual US sales of approximately $2.7 billion for the twelve months ending June, 2012 (IMS Health Sales Data).

Lupin has a vibrant presence in the Indian pharmaceuticals market and has over the past several years made major strides in expanding its therapy portfolio. The company has a robust promotion and distribution setup along with a strong presence in various therapeutic areas, including the fast growing diabetes market.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×